A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease
Clinical trial NCT03782376 · COMPLETED
Trial details
- NCT number
- NCT03782376
- Sponsor
- Janssen-Cilag Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-20
- Primary completion
- 2022-08-19
- Enrollment
- 215
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.